Tapewire

Nasdaq · USD

SLDB

Solid Biosciences Inc.

Export transactions ↓
Tapewire entity
4915
SEC CIK
0001707502
Parsed reports
381

Last 12 months

Inside the activity.

0 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202504
Jan 202603
Feb 2026020
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 31, 2026 Filed Feb 3, 2026 01:07 UTC
Ganot IlanDirector
Exercise / conversionRestricted Stock Units · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 6

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 45,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary

F6 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:07 UTC
Ganot IlanDirector
Exercise / conversionCommon Stock 15,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · nonDerivative · entry 1

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 32,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:18 UTC
Tan KevinCFO & Treasurer
Exercise / conversionRestricted Stock Units · Derivative 33,075 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 7

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 99,225

Underlying: Common Stock · 33,075 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 132,300 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 132,300 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:18 UTC
Tan KevinCFO & Treasurer
Exercise / conversionCommon Stock 33,075 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034089 · ownership.xml · nonDerivative · entry 2

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,821

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:16 UTC
Cumbo AlexanderDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 100,400 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 7

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 301,200

Underlying: Common Stock · 100,400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 401,600 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 401,600 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:16 UTC
Cumbo AlexanderDirector · President and CEO
Exercise / conversionCommon Stock 100,400 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034087 · ownership.xml · nonDerivative · entry 2

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 351,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:15 UTC
Hanrahan JessieChief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 27,625 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 7

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,875

Underlying: Common Stock · 27,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 110,500 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 110,500 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:15 UTC
Hanrahan JessieChief Regulatory Officer
Exercise / conversionCommon Stock 27,625 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034085 · ownership.xml · nonDerivative · entry 2

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:14 UTC
Brooks GabrielChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 28,225 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 7

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,675

Underlying: Common Stock · 28,225 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F9 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 112,900 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

F9 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 112,900 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:14 UTC
Brooks GabrielChief Medical Officer
Exercise / conversionCommon Stock 28,225 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034083 · ownership.xml · nonDerivative · entry 2

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:12 UTC
Howton David TChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 42,275 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 7

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,825

Underlying: Common Stock · 42,275 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:12 UTC
Howton David TChief Operating Officer
Exercise / conversionCommon Stock 42,275 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034080 · ownership.xml · nonDerivative · entry 2

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:09 UTC
Herzich PaulChief Technology Officer
Exercise / conversionRestricted Stock Units · Derivative 24,675 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 7

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,025

Underlying: Common Stock · 24,675 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 98,700 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 98,700 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 01:09 UTC
Herzich PaulChief Technology Officer
Exercise / conversionCommon Stock 24,675 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034076 · ownership.xml · nonDerivative · entry 2

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,222

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:07 UTC
Ganot IlanDirector
GrantRestricted Stock Units · Derivative 35,450 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 35,450

Underlying: Common Stock · 35,450 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F5 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:07 UTC
Ganot IlanDirector
GrantEmployee Stock Option (Right to Buy) · Derivative 70,900 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 4

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 70,900

Underlying: Common Stock · 70,900 shares

Expires 2036-01-29

F4 · derivative.exercise_date: This option was granted on January 29, 2026 (the "2026 Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:18 UTC
Tan KevinCFO & Treasurer
GrantRestricted Stock Units · Derivative 93,500 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 6

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,500

Underlying: Common Stock · 93,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:18 UTC
Tan KevinCFO & Treasurer
GrantEmployee Stock Option (Right to Buy) · Derivative 187,000 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 5

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,000

Underlying: Common Stock · 187,000 shares

Expires 2036-01-29

F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:18 UTC
Tan KevinCFO & Treasurer
Exercise / conversionPerformance Stock Units · Derivative 56,646 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 4

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 56,646 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:18 UTC
Tan KevinCFO & Treasurer
Exercise / conversionCommon Stock 56,646 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034089 · ownership.xml · nonDerivative · entry 1

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,746

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:16 UTC
Cumbo AlexanderDirector · President and CEO
GrantRestricted Stock Units · Derivative 254,900 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 6

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 254,900

Underlying: Common Stock · 254,900 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:16 UTC
Cumbo AlexanderDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 509,850 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 5

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 509,850

Underlying: Common Stock · 509,850 shares

Expires 2036-01-29

F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:16 UTC
Cumbo AlexanderDirector · President and CEO
Exercise / conversionPerformance Stock Units · Derivative 169,401 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 4

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 169,401 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:16 UTC
Cumbo AlexanderDirector · President and CEO
Exercise / conversionCommon Stock 169,401 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034087 · ownership.xml · nonDerivative · entry 1

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 250,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:15 UTC
Hanrahan JessieChief Regulatory Officer
GrantRestricted Stock Units · Derivative 95,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 6

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 95,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:15 UTC
Hanrahan JessieChief Regulatory Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 190,000 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 5

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock · 190,000 shares

Expires 2036-01-29

F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:15 UTC
Hanrahan JessieChief Regulatory Officer
Exercise / conversionPerformance Stock Units · Derivative 54,925 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 4

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,925 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:15 UTC
Hanrahan JessieChief Regulatory Officer
Exercise / conversionCommon Stock 54,925 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034085 · ownership.xml · nonDerivative · entry 1

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,585

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:14 UTC
Brooks GabrielChief Medical Officer
GrantRestricted Stock Units · Derivative 103,750 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 6

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,750

Underlying: Common Stock · 103,750 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F8 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F8 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:14 UTC
Brooks GabrielChief Medical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 207,450 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 5

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 207,450

Underlying: Common Stock · 207,450 shares

Expires 2036-01-29

F7 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:14 UTC
Brooks GabrielChief Medical Officer
Exercise / conversionPerformance Stock Units · Derivative 58,847 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 4

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 58,847 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis (the "PSUs").

F6 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

F6 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:14 UTC
Brooks GabrielChief Medical Officer
Exercise / conversionCommon Stock 58,847 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034083 · ownership.xml · nonDerivative · entry 1

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,818

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis (the "PSUs").

F2 · balance_after: Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 28, 2025.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:12 UTC
Howton David TChief Operating Officer
GrantRestricted Stock Units · Derivative 105,100 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 6

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,100

Underlying: Common Stock · 105,100 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:12 UTC
Howton David TChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 210,200 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 5

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,200

Underlying: Common Stock · 210,200 shares

Expires 2036-01-29

F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:12 UTC
Howton David TChief Operating Officer
Exercise / conversionPerformance Stock Units · Derivative 79,341 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 4

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 79,341 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:12 UTC
Howton David TChief Operating Officer
Exercise / conversionCommon Stock 79,341 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034080 · ownership.xml · nonDerivative · entry 1

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,249

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:09 UTC
Herzich PaulChief Technology Officer
GrantRestricted Stock Units · Derivative 85,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 6

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.

F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:09 UTC
Herzich PaulChief Technology Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 170,000 $0.00 Strike: $6.60 $0.00
Disclosure

SEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 5

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires 2036-01-29

F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:09 UTC
Herzich PaulChief Technology Officer
Exercise / conversionPerformance Stock Units · Derivative 54,925 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 4

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,925 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.

Read SEC document
January 29, 2026 Filed Feb 3, 2026 01:09 UTC
Herzich PaulChief Technology Officer
Exercise / conversionCommon Stock 54,925 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-034076 · ownership.xml · nonDerivative · entry 1

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.

Read SEC document
January 29, 2026 Filed Apr 21, 2026 20:05 UTC
Howton David TChief Operating Officer
GrantRestricted Stock Units · Derivative 79,341 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-166736 · ownership.xml · derivative · entry 1

Howton David T · CIK 0001529297 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,341

Underlying: Common Stock · 79,341 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

Read SEC document
January 29, 2026 Filed Apr 21, 2026 20:05 UTC
Brooks GabrielChief Medical Officer
GrantRestricted Stock Units · Derivative 58,847 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-166734 · ownership.xml · derivative · entry 1

Brooks Gabriel · CIK 0001997809 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,847

Underlying: Common Stock · 58,847 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

Read SEC document
January 29, 2026 Filed Apr 21, 2026 20:05 UTC
Cumbo AlexanderDirector · President and CEO
GrantRestricted Stock Units · Derivative 169,401 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-166735 · ownership.xml · derivative · entry 1

Cumbo Alexander · CIK 0001685994 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 169,401

Underlying: Common Stock · 169,401 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

Read SEC document
January 29, 2026 Filed Apr 21, 2026 20:05 UTC
Herzich PaulChief Technology Officer
GrantRestricted Stock Units · Derivative 54,925 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-166733 · ownership.xml · derivative · entry 1

Herzich Paul · CIK 0001954991 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,925

Underlying: Common Stock · 54,925 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

Read SEC document
January 29, 2026 Filed Apr 21, 2026 20:05 UTC
Tan KevinCFO & Treasurer
GrantRestricted Stock Units · Derivative 56,647 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-166732 · ownership.xml · derivative · entry 1

Tan Kevin · CIK 0001884056 · CFO & Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,647

Underlying: Common Stock · 56,647 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

Read SEC document
January 29, 2026 Filed Apr 21, 2026 20:05 UTC
Hanrahan JessieChief Regulatory Officer
GrantRestricted Stock Units · Derivative 54,925 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-166731 · ownership.xml · derivative · entry 1

Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,925

Underlying: Common Stock · 54,925 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").

F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027.

Read SEC document
January 28, 2026 Filed Jan 30, 2026 21:05 UTC
Ganot IlanDirector
SaleCommon Stock 191 $6.59 $1,258.69
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · nonDerivative · entry 2

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 17,476

F2 · kind: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

Read SEC document
January 27, 2026 Filed Jan 30, 2026 21:05 UTC
Ganot IlanDirector
Exercise / conversionRestricted Stock Units · Derivative 3,884 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · derivative · entry 6

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,884 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F6 · derivative.exercise_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F6 · derivative.expiration_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2026 Filed Jan 30, 2026 21:05 UTC
Ganot IlanDirector
Exercise / conversionRestricted Stock Units · Derivative 389 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · derivative · entry 5

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Wife

Disclosed balance after: 0

Underlying: Common Stock · 389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

F5 · derivative.expiration_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.

Read SEC document
January 27, 2026 Filed Jan 30, 2026 21:05 UTC
Ganot IlanDirector
Exercise / conversionCommon Stock 3,884 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-031765 · ownership.xml · nonDerivative · entry 3

Ganot Ilan · CIK 0001727460 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 99,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · ownership.direct: Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.